MB097
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MB097, covering 2025-09-26 to 2025-09-26. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients [Phase 1]